Emerging Medication in Australia: A Promising Breakthrough for Obesity Management ?
Australia is currently observing the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor agonist , representing a exciting advance in obesity treatment . Early clinical trials have demonstrated impressive results, showing greater impact than existing treatments like semaglutide. Wh